For the rest of the study, it remained at a significantly lower level, compared to the initial one
In contrast to earlier GLP-1 receptor agonists, which primarily target appetite suppression and glycemic improvement, GLP-3 leverages GCG receptor activation to stimulate lipolysis and elevate basal metabolic rate, thereby contributing to a more pronounced and sustained reduction in adiposity as observed in research models
While they can remove body fat from specific areas, they wont stop you from gaining weight elsewhere
I have patients who cannot tolerate Wegovy (semaglutide) but can tolerate Zepbound (tirzepatide), or, alternatively, they tolerate Wegovy but not Zepbound," she says
Lower doses reduce the hormonal spikes that cause them keeping treatment tolerable, consistent, and easier to sustain
The solution is straightforward: split the dose into two injections administered at different sites within the same session